Researcher

Huiping Li

Peking University

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 25, 2026 · JOURNAL ARTICLE

A case report of a patient with chronic granulomatous disease complicated by invasive aspergillosis and disseminated Burkholderia multivorans infection

Frontiers in Medicine

A single fatal case report documenting an unusual dual infection in CGD with a novel genetic mutation; raises clinical awareness but provides no comparative data or interventional evidence.

PreliminaryHuiping Li Xuanwen Weng Heng Zhang

Reported

Age at presentation14 years old

Duration to deathday 14 of hospitalization

Genetic mutation identifiedc.1514T>A (p.Leu505Gln) in CYBB gene

AUG 18, 2026 · JOURNAL ARTICLE

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: Real-World Outcomes and Treatment Transition Patterns in a Chinese Cohort

Current Oncology

Real-world retrospective cohort study demonstrating clinically meaningful efficacy and safety of T-DXd in heavily pretreated HER2-positive metastatic breast cancer, but limited by single-center design, lack of comparator arm, and acknowledged biases in maintenance analysis.

PromisingYaxin Liu Huiping Li Ruyan Zhang

Reported

Sample size173

Median follow-up14.3 months

Median progression-free survival14.1 months